Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Regan, Meredith M.Price, Karen N.Giobbie-Hurder, AnitaThürlimann, BeatGelber, Richard D.Horváth, Zsolt2016-12-292016-12-292011Breast Cancer Research. - 13 (2011), p. 209-224. -Breast Cancer Res. - 1465-54111465-5411http://hdl.handle.net/2437/233427Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancerfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM066526OrvostudományokKlinikai orvostudományokhttp://download.springer.com/static/pdf/953/art%253A10.1186%252Fbcr2837.pdf?originUrl=http%3A%2F%2Fbreast-cancer-research.biomedcentral.com%2Farticle%2F10.1186%2Fbcr2837&token2=exp=1482995569~acl=%2Fstatic%2Fpdf%2F953%2Fart%25253A10.1186%25252Fbcr2837.pdf*~hmac=d7eecaaf5b902a67c567ff07815d48f77d4fbe4920047a45ec5f7198514037a2BioMed Central2017-12-01